Rezolute (RZLT) Net Equity Issued and Repurchased (2010 - 2022)

Rezolute (RZLT) posted Net Equity Issued and Repurchased of $12.3 million for Q3 2022, up 1232900.0% sequentially from $1000.0 in Q2 2022, and up 927.5% YoY from $1.2 million in Q3 2021.

Rezolute (RZLT) Net Equity Issued and Repurchased (2010 - 2022) Analysis & Trends

Rezolute has reported Net Equity Issued and Repurchased for 10 years, with the latest figure at $12.3 million in Q3 2022.

  • Quarterly Net Equity Issued and Repurchased rose 927.5% year-over-year to $12.3 million in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $12.3 million (up 952.05% YoY) and the FY2025 annual result came in at $76.2 million, up 55.44% from the prior year.
  • Net Equity Issued and Repurchased rose to $12.3 million in Q3 2022 per RZLT's latest filing, from $1000.0 in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $49.5 million in Q4 2021 and troughed at -$49.6 million in Q1 2022.
  • A 4-year average of $4.3 million and a median of $1.5 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
  • The sharpest annual moves came in 2020 and 2021: Net Equity Issued and Repurchased soared 139.47% in 2020, then jumped 3202.53% in 2021.
  • Over 4 years, Net Equity Issued and Repurchased stood at -$3.8 million in 2019, then surged by 139.47% to $1.5 million in 2020, then surged by 3202.53% to $49.5 million in 2021, then plunged by 75.11% to $12.3 million in 2022.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $12.3 million, $1000.0, and -$49.6 million for Q3 2022, Q2 2022, and Q1 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Rezolute 442.94 Mn 442.94 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 12.33 Mn
Sep 30, 2022 12.33 Mn
Jun 30, 2022 1,000.00
Jun 30, 2022 1,000.00
Mar 31, 2022 -49.57 Mn
Mar 31, 2022 -49.57 Mn
Dec 31, 2021 49.54 Mn
Dec 31, 2021 49.54 Mn
Sep 30, 2021 1.20 Mn
Sep 30, 2021 1.20 Mn
Dec 31, 2020 1.50 Mn
Dec 31, 2020 1.50 Mn
Jun 30, 2020 24.05 Mn
Jun 30, 2020 24.05 Mn
Dec 31, 2019 -3.80 Mn
Dec 31, 2019 -3.80 Mn
Sep 30, 2019 3.80 Mn
Sep 30, 2019 3.80 Mn
Sep 30, 2017 4.50 Mn
Sep 30, 2017 4.50 Mn